These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35410270)

  • 21. Identification of a dominant linear epitope on the VP2 capsid protein of porcine parvovirus and characterization of two monoclonal antibodies with neutralizing abilities.
    Liu Y; Wang J; Chen Y; Wang A; Wei Q; Yang S; Feng H; Chai S; Liu D; Zhang G
    Int J Biol Macromol; 2020 Nov; 163():2013-2022. PubMed ID: 32931829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Potential Novel B-Cell Epitopes of Capsid Protein VP2 in Senecavirus A.
    Ru Y; Hao R; Wu C; Li Y; Lu B; Liu H; Tian H; Li D; Shi Z; Luo J; Ma K; Zhang G; Liu X; Zheng H
    Microbiol Spectr; 2023 Aug; 11(4):e0447222. PubMed ID: 37428080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Evaluation of a Competitive Enzyme-Linked Immunosorbent Assay Based on Swine Monoclonal Antibodies for Detecting Neutralizing Antibodies against Senecavirus A.
    Ma X; Huang J; Li K; Ding K; Fu Y; Zhang J; Zhao Z; Li P; Bai X; Li D; Liu X; Zeng Q; Liu Z; Sun P; Lu Z
    Microbiol Spectr; 2023 Jun; 11(3):e0459922. PubMed ID: 37036366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.
    Xu L; He D; Li Z; Zheng J; Yang L; Yu M; Yu H; Chen Y; Que Y; Shih JW; Liu G; Zhang J; Zhao Q; Cheng T; Xia N
    Theranostics; 2014; 4(5):498-513. PubMed ID: 24669278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
    Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
    J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Immunoreactivity and Protection Efficacy of Seneca Valley Virus Inactivated Vaccine in Finishing Pigs Based on Screening of Inactivated Agents and Adjuvants.
    Liu W; Li X; Zhang H; Hao G; Shang X; Wang H; Chen H; Qian P
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an indirect ELISA using a novel linear epitope at the C-terminal region of the VP2 protein to specifically detect antibodies against Senecavirus A.
    Ma Z; Lv J; Zhang Z; Pan L
    Virol J; 2022 Dec; 19(1):204. PubMed ID: 36461023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.
    Kaever T; Meng X; Matho MH; Schlossman A; Li S; Sela-Culang I; Ofran Y; Buller M; Crump RW; Parker S; Frazier A; Crotty S; Zajonc DM; Peters B; Xiang Y
    J Virol; 2014 Oct; 88(19):11339-55. PubMed ID: 25031354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.
    Kiener TK; Jia Q; Lim XF; He F; Meng T; Chow VT; Kwang J
    Virol J; 2012 Feb; 9():55. PubMed ID: 22361222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular evolution and characterization of novel Seneca Valley virus (SVV) strains in South China.
    Wang M; Chen L; Pan S; Mou C; Shi K; Chen Z
    Infect Genet Evol; 2019 Apr; 69():1-7. PubMed ID: 30639519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of three linear B cell epitopes using monoclonal antibodies against bovine enterovirus VP2 protein.
    Liu D; Hu J; Dong H; Huang L; Wei Y; Xia D; Zhu H; Wang X; Wu H; Wang X; Liu C
    Appl Microbiol Biotechnol; 2019 Sep; 103(18):7467-7480. PubMed ID: 31253999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of three PPV1 VP2 protein-specific B cell linear epitopes using monoclonal antibodies against baculovirus-expressed recombinant VP2 protein.
    Sun J; Huang L; Wei Y; Wang Y; Chen D; Du W; Wu H; Feng L; Liu C
    Appl Microbiol Biotechnol; 2015 Nov; 99(21):9025-36. PubMed ID: 26153140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An indirect enzyme-linked immunosorbent assay for the identification of antibodies to Senecavirus A in swine.
    Dvorak CM; Akkutay-Yoldar Z; Stone SR; Tousignant SJ; Vannucci FA; Murtaugh MP
    BMC Vet Res; 2017 Feb; 13(1):50. PubMed ID: 28202026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercellular transmission of Seneca Valley virus mediated by exosomes.
    Xu G; Xu S; Shi X; Shen C; Hao J; Yan M; Zhang D; Zhu Z; Zhang K; Zheng H; Liu X
    Vet Res; 2020 Jul; 51(1):91. PubMed ID: 32678013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of B-cell epitopes on structural proteins VP1 and VP2 of Senecavirus A and development of a multi-epitope recombinant protein vaccine.
    Zhang Z; Yao F; Lv J; Ding Y; Liu X; Zhang L; Ma Z; Zhou P; Wang Y; Guo H; Pan L
    Virology; 2023 May; 582():48-56. PubMed ID: 37023612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Neutralizing Epitope of PEDV S1 Protein Identified by IgM Monoclonal Antibody.
    Thavorasak T; Chulanetra M; Glab-Ampai K; Teeranitayatarn K; Songserm T; Yodsheewan R; Sae-Lim N; Lekcharoensuk P; Sookrung N; Chaicumpa W
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Structure-Guided Genetic Modification Strategy: Developing Seneca Valley Virus Therapy against Nonsensitive Nonsmall Cell Lung Carcinoma.
    Zhao Z; Cao L; Sun Z; Liu W; Li X; Fang K; Shang X; Hu J; Chen H; Lou Z; Qian P
    J Virol; 2023 May; 97(5):e0045923. PubMed ID: 37097154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Hu Z; Zhao J; Shi L; Hu J; Hu S; Liu X
    Virus Res; 2021 Jun; 298():198409. PubMed ID: 33819520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of a novel B-cell epitope on Aleutian Mink Disease virus capsid protein VP2 using a monoclonal antibody.
    Lu T; Wang Y; Ge J; Ma Q; Yan W; Zhang Y; Zhao L; Chen H
    Virus Res; 2018 Mar; 248():74-79. PubMed ID: 29278728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of multiplex real-time RT-PCR assays for the detection and differentiation of foot-and-mouth disease virus and Seneca Valley virus 1.
    Wang Y; Das A; Zheng W; Porter E; Xu L; Noll L; Liu X; Dodd K; Jia W; Bai J
    Transbound Emerg Dis; 2020 Mar; 67(2):604-616. PubMed ID: 31550077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.